Efficacy and safety of herbal medicine (Dangguijagyag-san) for primary dysmenorrhea: study protocol for a randomized, double-blind, placebo-controlled, parallel-group, multi-center trial

Dawood, 2006, Primary dysmenorrhea: Advances in pathogenesis and management, Obstet Gynecol, 108, 428, 10.1097/01.AOG.0000230214.26638.0c Shah, 2013, A study of prevalence of primary dysmenorrhea in young students-A cross-sectional study, Healthline, 4, 30 Unsal, 2010, Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students, Ups J Med Sci, 115, 138, 10.3109/03009730903457218 Burnett, 2005, Prevalence of primary dysmenorrhea in Canada, J Obstet Gynaecol Canada, 27, 765, 10.1016/S1701-2163(16)30728-9 Ng, 1992, A prevalence study of dysmenorrhoea in female residents aged 15-54 years in Clementi Town, Singapore, Ann Acad Med Singap, 21, 323 Hillen, 1999, Primary dysmenorrhea in young Western Australian women: Prevalence, impact, and knowledge of treatment, J Adolesc Health, 25, 40, 10.1016/S1054-139X(98)00147-5 Harlow, 1996, A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women, Bjog Int J Obstet Gynaecol, 103, 1134, 10.1111/j.1471-0528.1996.tb09597.x Lefebvre, 2005, Primary dysmenorrhea consensus guideline, J Obstet Gynaecol Can, 27, 1117, 10.1016/S1701-2163(16)30395-4 Marjoribanks, 2010, Nonsteroidal anti-inflammatory drugs for dysmenorrhoea, Cochrane Database Syst Rev, 10.1002/14651858.CD001751.pub2 Wong, 2009, Oral contraceptive pill as treatment for primary dysmenorrhoea, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD002120.pub2 Woo, 2017, A Survey on Korean Medicine Doctors’ Recognition and Clinical Fields of Treating Primary Dysmenorrhea for Developing Korean Medicine Clinical Practice Guideline for Dysmenorrhea, J Korean Obstet Gynecol, 30, 093 Pan, 2014, The traditional Chinese medicine prescription pattern of patients with primary dysmenorrhea in Taiwan: A large-scale cross sectional survey, J Ethnopharmacol, 152, 314, 10.1016/j.jep.2014.01.002 Wang, 2015, [Mechanism study on Danggui Shaoyao San and Guizhi Fuling wan for treating primary dysmenorrheal based on biological network], Zhong Yao Cai, 38, 2348 Usuki, 2002, The improvement of luteal insufficiency in fecund women by tokishakuyakusan treatment, Am J Chin Med (Gard City N Y), 30, 327, 10.1142/S0192415X02000247 Chung, 2008, Estrogenic effects of a Kampo formula, Tokishakuyakusan, in parous ovariectomized rats, Biol Pharm Bull, 31, 1145, 10.1248/bpb.31.1145 Lee, 2012, Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions, J Ethnopharmacol, 139, 883, 10.1016/j.jep.2011.12.015 Lee, 2016, Herbal medicine (Danggui Shaoyao San) for treating primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials, Maturitas, 85, 19, 10.1016/j.maturitas.2015.11.013 Chan, 2013, SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials, BMJ, 346, e7586, 10.1136/bmj.e7586 Osayande, 2014, Diagnosis and initial management of dysmenorrhea, Am Fam Physician, 89, 341 Cheng, 2017, CONSORT extension for chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration, Ann Intern Med, 10.7326/M16-2977 Gerlinger, 2010, Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: Analyses of two placebo-controlled, randomized trials, Health Qual Life Outcomes, 8, 138, 10.1186/1477-7525-8-138 Proctor, 2007, Dysmenorrhoea, BMJ Clin Evid, 2007, 813 Andersch, 1982, An epidemiologic study of young women with dysmenorrhea, Am J Obstet Gynecol, 144, 655, 10.1016/0002-9378(82)90433-1 Park, 2013, Development of a valid and reliable blood stasis questionnaire and its relationship to heart rate variability, Complement Ther Med, 21, 633, 10.1016/j.ctim.2013.08.019 Cox, 1978, Behavioral treatment parameters with primary dysmenorrhea, J Behav Med, 1, 297, 10.1007/BF00846681 Kim, 2004, Reliability and validity of the short-form McGill pain questionnaire (SF-MPQ) korean version for measuring the old adult’s pain, Clin Nurs Res, 10, 20 Okitsu, 2012, Development of a questionnaire for the diagnosis of Qi stagnation, Complement Ther Med, 20, 207, 10.1016/j.ctim.2011.12.005 Trotti, 2003 Deng, 2010, 46 Cases of treating dysmenorrhea with Xiaoyao San, Inner Mongol Journal of Traditional Chinese Medicine, 13 Qu, 2015, Efficacy of modified Xiaoyao San on primary dysmenorrhea among secondary vocational school female students, Modern Traditional Chinese Medicine, 35, 53 Xie, 2013, 50 cases of treating dysmenorrhea with Qi and blood stasis and stagnation with modified Xiaoyao San, Heilongjiang Journal of Traditional Chinese Medicine, 29 Park, 2013, Effects and safety of gyejibongnyeong-hwan on dysmenorrhea caused by blood stagnation: A randomized controlled trial, Evid Based Complement Altern Med, 2013, 10.1155/2013/424730 Choi, 2016, Evaluation on anti-oxidant activity and anti-inflammatory effects for the new formulation of Gamisoyosan, Korea J Herbol, 31, 1, 10.6116/kjh.2016.31.6.1. Iacovides, 2014, Reduced quality of life when experiencing menstrual pain in women with primary dysmenorrhea, Acta Obstet Gynecol Scand, 93, 213, 10.1111/aogs.12287 Lu, 2004, Theory of traditional Chinese medicine and therapeutic method of diseases, World Journal of Gastroenterology: WJG, 10, 1854, 10.3748/wjg.v10.i13.1854